IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – August 12, Read More
FLEX Study Highlights Clinical Utility of MammaPrint® and BluePrint® Read More
FLEX Study reaches milestone of 20,000 enrolled patients, providing Read More
Real-world analysis shows BluePrint® identifies chemotherapy-sensitive Basal-type tumors among Read More
Poster presentation to highlight new data on MammaPrint® and Read More
IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – February 11, Read More
Year-to-Date Achievements Demonstrate Significant Signs of Growth Across All Read More
Gene expression analysis reveals MammaPrint® as the only commercially Read More
New data reinforces findings from MINDACT supporting MammaPrint® in Read More
A secondary analysis of the randomized controlled trial, IDEAL, Read More
Contact
For the US, Puerto Rico, Canada
and South America
Agendia Inc. USA, 22 Morgan, Irvine, CA 92618
(888) 321-2732
customercare@agendia.com
For outside the Americas
Agendia NV, Radarweg 60, 1043 NT Amsterdam, The Netherlands
+31 (0)20 462 1510
customerservice@agendia.com
©2025 Agendia. All rights reserved. MammaPrint and Blueprint are registered trademarks of Agendia, Inc.
CHIEF FINANCIAL OFFICER
Ron Kalfus, our Chief Financial Officer, joined Agendia in July 2025. He has over 20 years of leadership experience in both public and private companies within diagnostics/biotech, and brings extensive knowledge in financial operations and management. Prior to joining Agendia, Ron served as CFO at MDxHealth, Rosetta Genomics, and MabCure. Ron holds a MS in Accounting from Fairleigh Dickinson University and a BBA in Finance from the University of Georgia and is a licensed CPA.
CHIEF COMPLIANCE OFFICER
Stephanie has worked in compliance since 2005 and has extensive experience developing and managing programs to support compliance with global, federal, and state laws and regulations in the healthcare and biotech industries. Prior to joining Agendia, Stephanie spent a significant portion of her career serving as a compliance officer in laboratories, such as HealthTrackRx, NeoGenomics, and Myriad Genetics, and held compliance leadership roles in medical device, pharma, and large health systems.
Stephanie graduated Summa Cum Laude with a B.S. in Healthcare Administration from Northern Illinois University and is Certified in Healthcare Compliance (CHC), Data Privacy (CHP), Research Compliance (CHRC), and is a Certified Internal Auditor (CIA).
